These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Drug Delivery Challenges and Current Progress in Nanocarrier-Based Ocular Therapeutic System. Akhter MH; Ahmad I; Alshahrani MY; Al-Harbi AI; Khalilullah H; Afzal O; Altamimi ASA; Najib Ullah SNM; Ojha A; Karim S Gels; 2022 Jan; 8(2):. PubMed ID: 35200463 [TBL] [Abstract][Full Text] [Related]
4. Promising therapeutic drug delivery systems for glaucoma: a comprehensive review. Singh RB; Ichhpujani P; Thakur S; Jindal S Ther Adv Ophthalmol; 2020; 12():2515841420905740. PubMed ID: 32206746 [TBL] [Abstract][Full Text] [Related]
5. Nano-based ocular drug delivery systems: an insight into the preclinical/clinical studies and their potential in the treatment of posterior ocular diseases. Su Y; Fan X; Pang Y Biomater Sci; 2023 Jun; 11(13):4490-4507. PubMed ID: 37222479 [TBL] [Abstract][Full Text] [Related]
6. Ocular Drug Delivery. Yavuz B; Kompella UB Handb Exp Pharmacol; 2017; 242():57-93. PubMed ID: 27783270 [TBL] [Abstract][Full Text] [Related]
7. A rabbit model for assessing the ocular barriers to the transscleral delivery of triamcinolone acetonide. Robinson MR; Lee SS; Kim H; Kim S; Lutz RJ; Galban C; Bungay PM; Yuan P; Wang NS; Kim J; Csaky KG Exp Eye Res; 2006 Mar; 82(3):479-87. PubMed ID: 16168412 [TBL] [Abstract][Full Text] [Related]
8. Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration. Amrite AC; Edelhauser HF; Singh SR; Kompella UB Mol Vis; 2008 Jan; 14():150-60. PubMed ID: 18334929 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of Topical and Subconjunctival Injection of Hyaluronic Acid-Coated Nanoparticles for Drug Delivery to Posterior Eye. Tsai CH; Hoang LN; Lin CC; Pan LC; Wu CL; Lin IC; Wang PY; Tseng CL Pharmaceutics; 2022 Jun; 14(6):. PubMed ID: 35745825 [TBL] [Abstract][Full Text] [Related]
11. Nanomedicines for back of the eye drug delivery, gene delivery, and imaging. Kompella UB; Amrite AC; Pacha Ravi R; Durazo SA Prog Retin Eye Res; 2013 Sep; 36():172-98. PubMed ID: 23603534 [TBL] [Abstract][Full Text] [Related]
12. Application of lipid nanoparticles to ocular drug delivery. Battaglia L; Serpe L; Foglietta F; Muntoni E; Gallarate M; Del Pozo Rodriguez A; Solinis MA Expert Opin Drug Deliv; 2016 Dec; 13(12):1743-1757. PubMed ID: 27291069 [TBL] [Abstract][Full Text] [Related]
13. Delivery of therapeutics for deep-seated ocular conditions - status quo. Nguyen H; Eng S; Ngo T; Dass CR J Pharm Pharmacol; 2018 Aug; 70(8):994-1001. PubMed ID: 29675844 [TBL] [Abstract][Full Text] [Related]
14. Nanoparticle-loaded biodegradable light-responsive in situ forming injectable implants for effective peptide delivery to the posterior segment of the eye. Bisht R; Jaiswal JK; Rupenthal ID Med Hypotheses; 2017 Jun; 103():5-9. PubMed ID: 28571808 [TBL] [Abstract][Full Text] [Related]
15. Applications of nanoparticles in ophthalmology. Diebold Y; Calonge M Prog Retin Eye Res; 2010 Nov; 29(6):596-609. PubMed ID: 20826225 [TBL] [Abstract][Full Text] [Related]
16. Multifunctional carboxymethyl chitosan derivatives-layered double hydroxide hybrid nanocomposites for efficient drug delivery to the posterior segment of the eye. Wang Y; Zhou L; Fang L; Cao F Acta Biomater; 2020 Mar; 104():104-114. PubMed ID: 31931169 [TBL] [Abstract][Full Text] [Related]
17. Ultrasound-mediated nanoparticle delivery across ex vivo bovine retina after intravitreal injection. Huang D; Chen YS; Thakur SS; Rupenthal ID Eur J Pharm Biopharm; 2017 Oct; 119():125-136. PubMed ID: 28602870 [TBL] [Abstract][Full Text] [Related]
18. Development of Timolol-Loaded Galactosylated Chitosan Nanoparticles and Evaluation of Their Potential for Ocular Drug Delivery. Zhao R; Li J; Wang J; Yin Z; Zhu Y; Liu W AAPS PharmSciTech; 2017 May; 18(4):997-1008. PubMed ID: 28101726 [TBL] [Abstract][Full Text] [Related]
19. Liposomes and nanotechnology in drug development: focus on ocular targets. Honda M; Asai T; Oku N; Araki Y; Tanaka M; Ebihara N Int J Nanomedicine; 2013; 8():495-503. PubMed ID: 23439842 [TBL] [Abstract][Full Text] [Related]
20. Novel Nanomicellar Formulation Approaches for Anterior and Posterior Segment Ocular Drug Delivery. Cholkar K; Patel A; Vadlapudi AD; Mitra AK Recent Pat Nanomed; 2012; 2(2):82-95. PubMed ID: 25400717 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]